APA

Stephens E. H., Blackmon S. H., Correa A. M., Roth J. A., Rice D. C., Hofstetter W., Benjamin R., Mehran R., Swisher S. G., Walsh G. L. & Vaporciyan A. A. (20110726). Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. : Journal of the American College of Surgeons.

Chicago

Stephens Elizabeth H, Blackmon Shanda H, Correa Arlene M, Roth Jack A, Rice David C, Hofstetter Wayne, Benjamin Robert, Mehran Reza, Swisher Stephen G, Walsh Garrett L and Vaporciyan Ara A. 20110726. Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. : Journal of the American College of Surgeons.

Harvard

Stephens E. H., Blackmon S. H., Correa A. M., Roth J. A., Rice D. C., Hofstetter W., Benjamin R., Mehran R., Swisher S. G., Walsh G. L. and Vaporciyan A. A. (20110726). Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. : Journal of the American College of Surgeons.

MLA

Stephens Elizabeth H, Blackmon Shanda H, Correa Arlene M, Roth Jack A, Rice David C, Hofstetter Wayne, Benjamin Robert, Mehran Reza, Swisher Stephen G, Walsh Garrett L and Vaporciyan Ara A. Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. : Journal of the American College of Surgeons. 20110726.